Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ian@SI who wrote (1615)	6/5/2003 12:35:09 PM
From: Icebrg	Read Replies (2) of 3044

Ian >>With all the potential Velcade indications, it alone could suck up all available financing and then some... >> The new partner to be announced will most probably have to take care of most of that. That's why MLNM are looking for a big pharma partner with a big wallet but few ideas of their own. Just compare with what BMY were prepared to do for Erbitux. Now, that was somewhat "unfortunate" from BMY's point of view and of course they overpaid heavily, but it goes to show that when a big pharma want something badly, they are prepared to pay a lot for it. And you will not see too many new paradigm drugs (unpartnered, approved and ready to run) over a 10-year period. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next